92 related articles for article (PubMed ID: 9879424)
1. Positron emission tomographic imaging of pleomorphic adenoma in the parotid gland.
Matsuda M; Sakamoto H; Okamura T; Nakai Y; Ohashi Y; Kawabe J; Ochi H; Wakasa K
Acta Otolaryngol Suppl; 1998; 538():214-20. PubMed ID: 9879424
[TBL] [Abstract][Full Text] [Related]
2. Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of parotid mass lesions.
Okamura T; Kawabe J; Koyama K; Ochi H; Yamada R; Sakamoto H; Matsuda M; Ohashi Y; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():209-13. PubMed ID: 9879423
[TBL] [Abstract][Full Text] [Related]
3. Retrospective review: usefulness of a number of imaging modalities including CT, MRI, technetium-99m pertechnetate scintigraphy, gallium-67 scintigraphy and F-18-FDG PET in the differentiation of benign from malignant parotid masses.
Ozawa N; Okamura T; Koyama K; Nakayama K; Kawabe J; Shiomi S; Yamane H; Inoue Y
Radiat Med; 2006 Jan; 24(1):41-9. PubMed ID: 16715661
[TBL] [Abstract][Full Text] [Related]
4. Metastasizing pleomorphic adenoma in the multiple organs: A case report on FDG-PET/CT imaging.
Koyama M; Terauchi T; Koizumi M; Tanaka H; Sato Y
Medicine (Baltimore); 2018 Jun; 97(23):e11077. PubMed ID: 29879077
[TBL] [Abstract][Full Text] [Related]
5. Correlation between FDG-PET findings and GLUT1 expression in salivary gland pleomorphic adenomas.
Horiuchi C; Tsukuda M; Taguchi T; Ishiguro Y; Okudera K; Inoue T
Ann Nucl Med; 2008 Oct; 22(8):693-8. PubMed ID: 18982472
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors.
Uchida Y; Minoshima S; Kawata T; Motoori K; Nakano K; Kazama T; Uno T; Okamoto Y; Ito H
Clin Nucl Med; 2005 Mar; 30(3):170-6. PubMed ID: 15722820
[TBL] [Abstract][Full Text] [Related]
7. Extraordinarily high F-18 FDG uptake caused by a pleomorphic adenoma of the parotid gland.
Wang KB; Hung GU; Lin WY
Clin Nucl Med; 2006 Oct; 31(10):638-9. PubMed ID: 16985375
[No Abstract] [Full Text] [Related]
8. 68Ga-DOTA-TOC Uptake in Pleomorphic Adenoma.
Laurens ST; Netea-Maier RT; Aarntzen EJHG
Clin Nucl Med; 2018 Jul; 43(7):524-525. PubMed ID: 29847321
[TBL] [Abstract][Full Text] [Related]
9. Parotid incidentaloma detected during thoracic PET imaging: how should these lesions be managed?
Thomas R; Sharma N; Burke C; Maxwell D; Howlett DC
Br J Hosp Med (Lond); 2010 May; 71(5):292-3. PubMed ID: 20448501
[TBL] [Abstract][Full Text] [Related]
10. Correlation between computed tomography imaging and histopathology in pleomorphic adenoma of parotid gland.
Kim H; Kim SY; Kim YJ; Ko JM; Park MJ; Kim JH; Hah JH; Kwon TK; Kim KH; Sung MW
Auris Nasus Larynx; 2018 Aug; 45(4):783-790. PubMed ID: 29055657
[TBL] [Abstract][Full Text] [Related]
11. Pleomorphic adenoma of parotid gland: delayed enhancement on computed tomography.
Brunese L; Ciccarelli R; Fucili S; Romeo A; Napolitano G; D'Auria V; Collina A; Califano L; Cappabianca S; Sodano A
Dentomaxillofac Radiol; 2008 Dec; 37(8):464-9. PubMed ID: 19033432
[TBL] [Abstract][Full Text] [Related]
12. Basal cell adenoma versus pleomorphic adenoma of the parotid gland: CT findings.
Chiu NC; Wu HM; Chou YH; Li WY; Chiou YY; Guo WY; Chang CY
AJR Am J Roentgenol; 2007 Nov; 189(5):W254-61. PubMed ID: 17954621
[TBL] [Abstract][Full Text] [Related]
13. Does 18F-FDG PET/CT play a role in the differential diagnosis of parotid masses.
Rubello D; Nanni C; Castellucci P; Rampin L; Farsad M; Franchi R; Mariani G; Menaldo G; Fanti S
Panminerva Med; 2005 Sep; 47(3):187-9. PubMed ID: 16462726
[TBL] [Abstract][Full Text] [Related]
14. Agenesis of the unilateral parotid gland associated with pleomorphic adenoma of the contralateral parotid gland.
Karakoc O; Akcam T; Kocaoglu M; Yetiser S
J Laryngol Otol; 2005 May; 119(5):409-11. PubMed ID: 15949111
[TBL] [Abstract][Full Text] [Related]
15. Pleomorphic adenoma of the salivary glands: correlation between gallium-67 uptake and histopathological components.
Yoshikai T; Yonemitsu N; Ishimaru J; Mihara M; Shin T; Kudo S
J Nucl Med; 1998 Mar; 39(3):537-41. PubMed ID: 9529306
[TBL] [Abstract][Full Text] [Related]
16. Recurrent pleomorphic adenoma of the parotid gland: A comparison of radiographic and pathologic tumor burden.
Rooker SA; Nagelschneider AA; Moore EJ; Yin LX; Price DL; Janus JR; Kasperbauer JL; Van Abel KM
Am J Otolaryngol; 2020; 41(6):102642. PubMed ID: 32682193
[TBL] [Abstract][Full Text] [Related]
17. Pleomorphic adenoma simulating metastatic squamous cell carcinoma on f-18 fluorodeoxyglucose positron emission tomography.
Mackie GC; Yarram SG
Clin Nucl Med; 2004 Nov; 29(11):743-4. PubMed ID: 15483498
[No Abstract] [Full Text] [Related]
18. Diagnostic value of metabolic heterogeneity as a reliable parameter for differentiating malignant parotid gland tumors.
Kim BS; Kim SJ; Pak K
Ann Nucl Med; 2016 Jun; 30(5):346-54. PubMed ID: 26897010
[TBL] [Abstract][Full Text] [Related]
19. Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors.
Uematsu H; Sadato N; Ohtsubo T; Tsuchida T; Nakamura S; Sugimoto K; Waki A; Takahashi N; Yonekura Y; Tsuda G; Saito H; Hayashi N; Yamamoto K; Ishii Y
J Nucl Med; 1998 Mar; 39(3):453-9. PubMed ID: 9529291
[TBL] [Abstract][Full Text] [Related]
20. Ossifying pleomorphic adenoma of the parotid gland: a case report and review.
Kato H; Kanematsu M; Ando K; Mizuta K; Ito Y; Hirose Y; Hoshi H
Australas Radiol; 2007 Dec; 51 Suppl():B173-5. PubMed ID: 17991056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
